The polymyalgia rheumatica drugs market is estimated to be valued at USD 266 Mn in 2024 and is expected to reach USD 662 Mn by 2031, growing at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031. https://www.zupyak.com/p/4494405/t/challenges-and-opportunities-in-the-polymyalgia-rheumatica-drugs-market